SUBSCRIBERS
Temasek pumping US$800 million into Alphabet's medical unit
It will get minority stake and board seat in Verily; deal will help latter expand into China
Add BT as a preferred sourcePublished Fri, Jan 27, 2017 · 09:50 PM
San Francisco
ALPHABET Inc's medical arm, Verily Life Sciences LLC, is getting a major influx of cash from a Singapore investment company, boosting the odds of taking their futuristic approach to healthcare into Asian markets.
Temasek Holdings Pte Ltd, with US$415.8 billion in assets, is investing US$800 million in Verily, according to a statement from the company on Thursday. In exchange, Temasek will get a minority stake in Verily and a seat on its operating board.
Share with us your feedback on BT's products and services
